Navigation Links
InterMune to Release Third Quarter Financial Results on October 28
Date:10/21/2010

BRISBANE, Calif., Oct. 21 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that it will release third quarter 2010 financial results on Thursday, October 28, 2010 at 4:00 p.m. Eastern time.  A live conference call and webcast will be hosted by InterMune at 4:30 p.m. Eastern time that same day.

To access the live teleconference, dial 888-567-5125 (U.S.) or 706-643-9223 (international), conference ID# 20132776.  To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.  

A replay of the webcast and teleconference will be available approximately three hours after the call.  The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 20132776.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology.  InterMune has an R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections.  The pulmonology portfolio includes pirfenidone for which InterMune has completed a Phase 3 program in patients with IPF (CAPACITY).  A Marketing Authorization Application (MAA) for pirfenidone is under review by the European Medicines Agency (EMA).  The hepatology portfolio includes next-generation HCV protease inhibitor and NS5A research programs.  For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.


'/>"/>
SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. InterMune to Present at Canaccord Adams Conference
2. InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
3. InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting
4. InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF
5. InterMune to Release Third Quarter 2008 Financial Results on November 6
6. InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
7. InterMune to Present at Deutsche Bank Biotech Boston Confab
8. InterMune to Present at J.P. Morgan Healthcare Conference
9. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
10. InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
11. InterMune Announces Issuance of U.S. Patent for ITMN-191
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 DTS Language ... its Online Web Portal for Life Science organizations who need ... specify the subject matter of their documents in advance with ... help reduce time-to-delivery of translations, often a critical factor in ...
(Date:1/15/2014)... ON (PRWEB) January 15, 2014 AudioNotch ... experimental new therapy for the treatment of tinnitus. Patients ... tinnitus frequency, and over a period of weeks to months, ... Sound Therapy in two forms: Notched Music and Notched White ...
(Date:1/14/2014)... 2014 Carahsoft and CDS Federal Services ... 2014 at 2pm EST (11am PST), “Natural Language Processing: ... on how technology can turn raw, heterogeneous data into ... agencies. The online webinar will last approximately one hour. ...
(Date:1/14/2014)... As pet owners drew up their lists of New Year,s resolutions ... care of my furry companion." Nowadays there are pet salons, dog ... to take the little canine or feline darlings along wherever mommy ... some pricey toys at the pet store. But anyone who has ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... Cytopia Limited (ASX: CYT) ("Cytopia") has today announced that ... an exclusive and binding Implementation Agreement ("Agreement") in which ... the issued shares and options in Cytopia. This transaction ... shareholders (and optionholders if required)(i) are expected to vote ...
... Sweden, October 5 , - A New Miniaturized ... the Price of QuanTyper(TM) Without Loss of Performance, ... , AlphaHelix (Ticker: ALPH) has in a ... demands for lower,instrument prices. This was made possible through know-how obtained ...
... 5 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) ... Williams, Ph.D., Chief Executive Officer of ZymoGenetics, Inc. (Nasdaq: ... pleased to welcome Doug to our board of directors ... to Oncothyreon. His extensive experience in drug development, research ...
Cached Biology Technology:Cytopia Merger with Toronto-based YM BioSciences Inc. 2Cytopia Merger with Toronto-based YM BioSciences Inc. 3Cytopia Merger with Toronto-based YM BioSciences Inc. 4Cytopia Merger with Toronto-based YM BioSciences Inc. 5Cytopia Merger with Toronto-based YM BioSciences Inc. 6Cytopia Merger with Toronto-based YM BioSciences Inc. 7AlphaHelix Presents AmpXpress(TM) at the BIOTECHNICA Show 2Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors 2
(Date:4/17/2014)... ALBUQUERQUE, N.M. A credit-card-sized anthrax detection cartridge developed ... small business makes testing safer, easier, faster and cheaper. ... causes anthrax, is commonly found in soils all over ... illness in both humans and animals. The bacteria can ... to B. anthracis may occur through skin ...
(Date:4/17/2014)... cells in bone marrow need to produce hydrogen sulfide ... according to a new study from the Center for ... Dentistry of USC. , Professor Songtao Shi, principal investigator ... produced by the cells governs the flow of calcium ... signals that results in osteogenesis, or the creation of ...
(Date:4/17/2014)... that devastate honeybees in Europe, Asia and the United ... appear to be impacting native honeybee populations at this ... invasive pests include including Nosema microsporidia and ... to be resilient to these invasive pests, which suggests ... in Europe, Asia and the United States currently are ...
Breaking Biology News(10 mins):Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3
... available in German . , Over 100,000 ... research, the factors that trigger the disease and influence its ... Neurobiology in Martinsried and an international research team have succeeded ... would appear that B cells play an unexpected role in ...
... in German . No progress ... medicine. The chances of cure for those affected can ... transferred from the laboratory into clinical practice. Framework conditions ... now be optimized in Germany. Last Tuesday, German Research ...
... throughout the Caribbean have been comprehensively ,flattened, over the last ... University of East Anglia (UEA). The collapse of reef ... a double whammy for fragile coastal communities in the region. ... the Caribbean was in decline, but this is the first ...
Cached Biology News:Tracking down the causes of multiple sclerosis 2Tracking down the causes of multiple sclerosis 3Tracking down the causes of multiple sclerosis 4German Research Minister Schavan: 'Rapid knowledge transfer can safe lives' 2German Research Minister Schavan: 'Rapid knowledge transfer can safe lives' 3Caribbean coral reefs flattened 2